Trial Profile
Intravascular ultrasound analysis of the new ABT-578 eluting phosphorylcholine-coated stent implantation to de novo human coronary lesions: the ENDEAVOR I trial.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary)
- Indications Coronary artery restenosis; Coronary disorders
- Focus Therapeutic Use
- Acronyms ENDEAVOR-I
- Sponsors Medtronic
- 05 Nov 2010 New trial record.